| 5-year survivors | Non-survivors | p Value | ||
| Age | <65 | 15 | 7 | 0.028 |
| ≥65 | 26 | 37 | ||
| Gender | Male | 35 | 41 | 0.239 |
| Female | 6 | 3 | ||
| Smoking status | Current/former | 39 | 39 | 0.269 |
| Never | 2 | 5 | ||
| p-stage | I | 28 | 21 | 0.054 |
| II-III | 13 | 23 | ||
| pT status | pT1 | 22 | 16 | 0.108 |
| pT2-3 | 19 | 28 | ||
| pN status | pN0 | 35 | 27 | 0.011 |
| pN1-2 | 6 | 17 | ||
| Tumor location | Central | 19 | 21 | 0.898 |
| Peripheral | 22 | 23 | ||
| IP | IP+ | 3 | 10 | 0.043 |
| IP− | 38 | 34 | ||
| CEA | Normal | 30 | 31 | 0.781 |
| High | 11 | 13 | ||
| SCC | Normal | 28 | 16 | 0.003 |
| High | 13 | 28 | ||
| CYFRA 21-1 | Normal | 29 | 18 | 0.005 |
| High | 12 | 26 | ||
| SCC & CYFRA 21-1 | Both normal | 23 | 9 | 0.001 |
| Others | 18 | 35 |